Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfandyar Mufti

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Journal of the American Academy of Dermatology|March 7, 2024
Use of biologic treatment in psoriasis patients with HIV: A systematic reviewSiddhartha Sood, Ryan Geng, Martin Heung, et al.
Journal of Cutaneous Medicine and Surgery|October 25, 2024
Tocilizumab for the Treatment of Refractory Morphea: A Systematic ReviewDea Metko, Shanti Mehta, Ryan Geng, et al.
Journal of the American Academy of Dermatology|September 14, 2020
Stevens-Johnson syndrome and toxic epidermal necrolysis reactions to BRAF and MEK inhibitors in patients with melanoma: A systematic reviewYuliya Lytvyn, Asfandyar Mufti, Muskaan Sachdeva, et al.
Journal of the American Academy of Dermatology|March 19, 2023
Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based reviewAbrahim Abduelmula, Siddhartha Sood, Asfandyar Mufti, et al.
JAAD International|August 19, 2021
Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter studyYuliya Lytvyn, Hiba Zaaroura, Asfandyar Mufti, et al.
Journal of the American Academy of Dermatology|October 3, 2020
Characteristics and treatment outcomes in chromhidrosis: A systematic reviewNadia Kashetsky, Asfandyar Mufti, Ahmed Bagit, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic reviewMuskaan Sachdeva, Asfandyar Mufti, Patrick Kim, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatmentMuskaan Sachdeva, Asfandyar Mufti, Khalad Maliyar, et al.
Journal of the American Academy of Dermatology|April 15, 2020
Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case seriesAsfandyar Mufti, Khalad Maliyar, Laura Walton, et al.
Journal of the American Academy of Dermatology|February 22, 2021
Effect of dupilumab on allergic contact dermatitis and patch testingChristine E Jo, Asfandyar Mufti, Muskaan Sachdeva, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Journal of the American Academy of Dermatology|March 7, 2024
Use of biologic treatment in psoriasis patients with HIV: A systematic reviewSiddhartha Sood, Ryan Geng, Martin Heung, et al.
Journal of Cutaneous Medicine and Surgery|October 25, 2024
Tocilizumab for the Treatment of Refractory Morphea: A Systematic ReviewDea Metko, Shanti Mehta, Ryan Geng, et al.
Journal of the American Academy of Dermatology|September 14, 2020
Stevens-Johnson syndrome and toxic epidermal necrolysis reactions to BRAF and MEK inhibitors in patients with melanoma: A systematic reviewYuliya Lytvyn, Asfandyar Mufti, Muskaan Sachdeva, et al.
Journal of the American Academy of Dermatology|March 19, 2023
Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based reviewAbrahim Abduelmula, Siddhartha Sood, Asfandyar Mufti, et al.
JAAD International|August 19, 2021
Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter studyYuliya Lytvyn, Hiba Zaaroura, Asfandyar Mufti, et al.
Journal of the American Academy of Dermatology|October 3, 2020
Characteristics and treatment outcomes in chromhidrosis: A systematic reviewNadia Kashetsky, Asfandyar Mufti, Ahmed Bagit, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic reviewMuskaan Sachdeva, Asfandyar Mufti, Patrick Kim, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatmentMuskaan Sachdeva, Asfandyar Mufti, Khalad Maliyar, et al.
Journal of the American Academy of Dermatology|April 15, 2020
Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case seriesAsfandyar Mufti, Khalad Maliyar, Laura Walton, et al.
Journal of the American Academy of Dermatology|February 22, 2021
Effect of dupilumab on allergic contact dermatitis and patch testingChristine E Jo, Asfandyar Mufti, Muskaan Sachdeva, et al.
Pageof 15